Autologous Stem Cell Transplantation for T-Cell Lymphomas

Research output: Contribution to journalArticlepeer-review


Peripheral T-cell lymphomas (PTCLs) are a rare and heterogeneous group of T-cell malignancies characterized by a very poor outcome. The optimal treatment for PTCLs remains controversial. The role of stem cell transplantation in PTCLs has been investigated; however, no randomized control studies specifically dedicated to PTCLs are currently available. Several retrospective and prospective studies have suggested that high-dose chemotherapy (HDT) followed by autologous stem cell transplantation (ASCT) may improve the survival in patients with chemosensitive T-cell lymphoma, either upfront or as salvage treatment. This review provides a summary of the current literature with the intent to explore the role of ASCT in various clinical scenarios.

Original languageEnglish
Pages (from-to)59-66
Number of pages8
JournalSeminars in Hematology
Issue number1
Publication statusPublished - Jan 2014

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Autologous Stem Cell Transplantation for T-Cell Lymphomas'. Together they form a unique fingerprint.

Cite this